| Primary |
| Colorectal Cancer Metastatic |
30.5% |
| Colorectal Cancer |
11.1% |
| Colon Cancer |
8.1% |
| Hypertension |
8.1% |
| Pain |
8.1% |
| Colon Cancer Metastatic |
4.9% |
| Prophylaxis |
4.5% |
| Gastrointestinal Stromal Tumour |
3.6% |
| Vomiting |
2.9% |
| Constipation |
2.7% |
| Abdominal Pain |
2.6% |
| Diabetes Mellitus |
2.5% |
| Nausea |
1.8% |
| Thrombosis Prophylaxis |
1.5% |
| Anxiety |
1.3% |
| Back Pain |
1.3% |
| Insomnia |
1.2% |
| Adenocarcinoma Of Colon |
1.1% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Urinary Tract Infection |
1.0% |
|
| Renal Failure Acute |
9.9% |
| Weight Decreased |
9.9% |
| General Physical Health Deterioration |
8.8% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
7.7% |
| Rash |
6.6% |
| Thrombocytopenia |
6.6% |
| Dehydration |
5.5% |
| Vomiting |
5.5% |
| Toxic Skin Eruption |
4.4% |
| Death |
3.3% |
| Dyspnoea |
3.3% |
| Metastases To Central Nervous System |
3.3% |
| Myocardial Infarction |
3.3% |
| Pancreatitis |
3.3% |
| Pneumonia |
3.3% |
| Pulmonary Embolism |
3.3% |
| Pyrexia |
3.3% |
| Stomatitis |
3.3% |
| Subileus |
3.3% |
| Atrial Fibrillation |
2.2% |
|
| Secondary |
| Colon Cancer |
33.3% |
| Colorectal Cancer Metastatic |
21.4% |
| Colorectal Cancer |
11.4% |
| Colon Cancer Metastatic |
7.4% |
| Hypertension |
4.2% |
| Vomiting |
3.6% |
| Pain |
3.1% |
| Gastrointestinal Stromal Tumour |
2.3% |
| Prophylaxis |
2.2% |
| Spinal Pain |
1.8% |
| Diabetes Mellitus |
1.5% |
| Adenocarcinoma Of Colon |
1.4% |
| Hepatocellular Carcinoma |
1.4% |
| Abdominal Pain |
1.3% |
| Constipation |
1.0% |
| Thrombosis Prophylaxis |
0.8% |
| Hypercholesterolaemia |
0.6% |
| Back Pain |
0.5% |
| Central Venous Catheterisation |
0.5% |
| Anxiety |
0.4% |
|
| Myocardial Infarction |
14.2% |
| Tachycardia Paroxysmal |
12.7% |
| Renal Failure Acute |
9.0% |
| Pulmonary Embolism |
7.5% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
5.7% |
| Thrombophlebitis Superficial |
5.7% |
| Pneumonia |
4.7% |
| Death |
4.2% |
| Neurofibromatosis |
4.2% |
| Wound Dehiscence |
4.2% |
| Atrial Fibrillation |
3.8% |
| Dehydration |
3.3% |
| General Physical Health Deterioration |
3.3% |
| Weight Decreased |
3.3% |
| Encephalopathy |
2.8% |
| Liver Abscess |
2.8% |
| Small Intestinal Obstruction |
2.8% |
| Pyrexia |
1.9% |
| Rash |
1.9% |
| Stomatitis |
1.9% |
|
| Concomitant |
| Colorectal Cancer Metastatic |
23.5% |
| Product Used For Unknown Indication |
11.8% |
| Atrial Fibrillation |
5.9% |
| Blood Iron Decreased |
5.9% |
| Cerebrovascular Accident Prophylaxis |
5.9% |
| Colorectal Cancer |
5.9% |
| Eye Pruritus |
5.9% |
| Hypersensitivity |
5.9% |
| Lacrimation Increased |
5.9% |
| Metastatic Neoplasm |
5.9% |
| Neoplasm Malignant |
5.9% |
| Pulmonary Embolism |
5.9% |
| Rhinorrhoea |
5.9% |
|
| Disease Progression |
25.0% |
| Drug Ineffective |
25.0% |
| Rectal Haemorrhage |
25.0% |
| Vision Blurred |
25.0% |
|
| Interacting |
| Colorectal Cancer Metastatic |
66.7% |
| Arrhythmia |
16.7% |
| Atrial Fibrillation |
16.7% |
|
|
